BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jakab SS, West AB, Meighan DM, Jr RSB, Hale WB. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome. World J Gastroenterol 2007; 13(45): 6087-6089 [DOI: 10.3748/wjg.v13.i45.6087]
URL: https://www.wjgnet.com/1007-9327/full/v13/i45/6087.htm
Number Citing Articles
1
Soraya Salas-Silva, Arturo Simoni-Nieves, Jocelyn Lopez-Ramirez, Leticia Bucio, Luis E. Gómez-Quiroz, María Concepción Gutiérrez-Ruiz, Marcelo G. Roma. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategiesLife Sciences 2019; 218: 324 doi: 10.1016/j.lfs.2018.12.044
2
CM Hall, S Glaser, G Alpini. Comprehensive Toxicology2018; : 52 doi: 10.1016/B978-0-323-95488-4.01004-4
3
Michele Visentin, Daniela Lenggenhager, Zhibo Gai, Gerd A. Kullak-Ublick. Drug-induced bile duct injuryBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1498 doi: 10.1016/j.bbadis.2017.08.033
4
Paul Wasuwanich, Hassan Choudry, Joshua M. So, Sarah Lowry, Wikrom Karnsakul. Vanishing bile duct syndrome after drug-induced liver injuryClinics and Research in Hepatology and Gastroenterology 2022; 46(9): 102015 doi: 10.1016/j.clinre.2022.102015